RECENT COMMENTS

Kathy Redmond: Readers may have noticed that ESO has deleted a number of comments on this article. This is because [...]   »Read more

Pongsri (Sex and cancer): I teach body image and sexuality in cancer survivors for specialty 4 month cancer nurse program. Thi [...]   »Read more

DR Jennifer L Scott (Sex and cancer): Togehter with my colleague Prof Karen Kayser I have published a review of RCT of interventions to en [...]   »Read more

Dr O. Abimbola Oluwatosin (Sex and cancer): I teach sexuality in Nursing at post graduate level. This article is very useful and will be added t [...]   »Read more

Dr. Yannis Vassiliou (political oncology): A great article, well done! I was deeply disappointed by the comments of the Turkish colleagues, wh [...]   »Read more

 

Article type: Grandround

Keywords: patient advocacy, clinical trials, cancer research, .

This article has 0 comments

Facebook Twitter Share - Send - Print - Pdf

 

No trials about us without us!

No trials about us
without us!

Patients are not scientists. But given the chance, they can help clinical researchers design trials that patients want to join and stay with, and that answer questions they care about. They want the culture of the consent form to be replaced by a genuine partnership between researchers and patients.

» Peter McIntyre


To read the complete article please click on the pdf icon
 
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck and Novartis.